Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
657.20    -5.80 (-0.87%)
Bid:
658.00
Ask:
658.20
Spread: 0.20 (0.03%)
Market Cap: £52.31b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Final Terms

10 Nov 2025 10:30

RNS Number : 8816G
NatWest Group plc
10 November 2025
 

NatWest Group plc

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 6 November 2025 (the "Final Terms") for the NatWest Group plc ("NatWest Group") GBP750,000,000 4.758% Fixed to Fixed Rate Reset Notes due November 2031 (ISIN: XS3225880387) (the "Notes") issued under the £40,000,000,000 Euro Medium Term Note Programme of NatWest Group (the "Programme").

The Final Terms contain the final terms of the Notes and must be read in conjunction with the prospectus dated 6 December 2024, the supplemental prospectuses dated 14 February 2025, 2 May 2025, 25 July 2025 and 24 October 2025 relating to the Programme, (together, the "Prospectus"), which together constitute a base prospectus for the purposes of the Prospectus Regulation (EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the European Union (Withdrawal) Act 2018.

To view the Final Terms for the Notes, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/8816G_1-2025-11-10.pdf

A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism  

For further information, please contact:

Scott Forrest

Head of NatWest Treasury DCM

Tel: +44 (0) 131 626 1329

 

 

DISCLAIMER INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the information in the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

Legal Entity Identifier

NatWest Group plc - 2138005O9XJIJN4JPN90

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTGPGQPGUPAGUU
Date   Source Headline
27th Dec 20235:18 pmRNSTransaction in Own Shares
22nd Dec 20231:27 pmRNSTransaction in Own Shares
21st Dec 20235:23 pmRNSTransaction in Own Shares
20th Dec 20235:35 pmRNSTransaction in Own Shares
19th Dec 20235:33 pmRNSTransaction in Own Shares
19th Dec 20233:00 pmRNSDirector/PDMR Shareholding
18th Dec 20235:31 pmRNSTransaction in Own Shares
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20239:00 amRNSKey findings from Phase 2 of Travers Smith review
13th Dec 20235:32 pmRNSTransaction in Own Shares
12th Dec 20235:29 pmRNSTransaction in Own Shares
11th Dec 20239:38 amRNSHolding(s) in Company
8th Dec 20239:46 amRNSPublication of a Prospectus
7th Dec 20235:18 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSTransaction in Own Shares
5th Dec 20235:07 pmRNSTransaction in Own Shares
4th Dec 20235:12 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares
1st Dec 20239:52 amRNSTotal Voting Rights
29th Nov 20235:57 pmRNSTransaction in Own Shares
28th Nov 20235:31 pmRNSTransaction in Own Shares
27th Nov 20235:35 pmRNSTransaction in Own Shares
24th Nov 20235:34 pmRNSTransaction in Own Shares
23rd Nov 20235:27 pmRNSTransaction in Own Shares
23rd Nov 20233:39 pmRNSDividend Declaration
22nd Nov 20235:39 pmRNSTransaction in Own Shares
22nd Nov 20238:30 amRNSJPMorgan UK Leaders Conference
21st Nov 20235:54 pmRNSTransaction in Own Shares
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
20th Nov 20235:09 pmRNSTransaction in Own Shares
16th Nov 20235:33 pmRNSTransaction in Own Shares
14th Nov 20235:36 pmRNSTransaction in Own Shares
13th Nov 20235:04 pmRNSTransaction in Own Shares
13th Nov 20237:00 amRNSQ3 2023 Pillar 3
10th Nov 20235:06 pmRNSTransaction in Own Shares
10th Nov 20239:30 amRNSSection 430 (2B) Companies Act 2006 Statement
9th Nov 20235:05 pmRNSTransaction in Own Shares
9th Nov 20232:00 pmRNSDirector/PDMR Shareholding
8th Nov 20235:14 pmRNSTransaction in Own Shares
6th Nov 20235:17 pmRNSTransaction in Own Shares
3rd Nov 20236:02 pmRNSTransaction in Own Shares
2nd Nov 20235:13 pmRNSTransaction in Own Shares
1st Nov 20235:38 pmRNSTransaction in Own Shares
31st Oct 20236:07 pmRNSTransaction in Own Shares
31st Oct 20235:51 pmRNSTotal Voting Rights
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
30th Oct 20235:56 pmRNSTransaction in Own Shares
27th Oct 20235:26 pmRNSTransaction in Own Shares
27th Oct 20234:59 pmRNSPublication of Supplementary Prospectus
27th Oct 20237:00 amRNSNWG plc Q3 2023 Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.